200 related articles for article (PubMed ID: 10744148)
1. Haemostatic and lipid determinants of prothrombin fragment F1.2 and D-dimer in plasma.
MacCallum PK; Cooper JA; Martin J; Howarth DJ; Meade TW; Miller GJ
Thromb Haemost; 2000 Mar; 83(3):421-6. PubMed ID: 10744148
[TBL] [Abstract][Full Text] [Related]
2. Elevated levels of prothrombin fragment 1 + 2 indicate high risk of thrombosis.
Ota S; Wada H; Abe Y; Yamada E; Sakaguchi A; Nishioka J; Hatada T; Ishikura K; Yamada N; Sudo A; Uchida A; Nobori T
Clin Appl Thromb Hemost; 2008 Jul; 14(3):279-85. PubMed ID: 18160575
[TBL] [Abstract][Full Text] [Related]
3. Dyslipidemias and fibrinolysis.
Puccetti L; Bruni F; Pasqui AL; Pastorelli M; Bova G; Cercignani M; Palazzuoli A; Auteri A
Ital Heart J; 2002 Oct; 3(10):579-86. PubMed ID: 12478815
[TBL] [Abstract][Full Text] [Related]
4. Early decrease in coagulation activity after myocardial infarction is associated with lower risk of new ischaemic events: observations from the ESTEEM Trial.
Christersson C; Oldgren J; Bylock A; Siegbahn A; Wallentin L
Eur Heart J; 2007 Mar; 28(6):692-8. PubMed ID: 17314111
[TBL] [Abstract][Full Text] [Related]
5. Plasma levels of prothrombin fragment F1+2, D-dimer and prothrombin time correlate with clinical stage and lymph node metastasis in operable gastric cancer patients.
Kwon HC; Oh SY; Lee S; Kim SH; Han JY; Koh RY; Kim MC; Kim HJ
Jpn J Clin Oncol; 2008 Jan; 38(1):2-7. PubMed ID: 18258711
[TBL] [Abstract][Full Text] [Related]
6. Changes in molecular markers of hemostatic and fibrinolytic activation under various sampling conditions using vacuum tube samples from healthy volunteers.
Omote M; Asakura H; Takamichi S; Shibayama M; Yoshida T; Kadohira Y; Maekawa M; Yamazaki M; Morishita E; Nakao S; Wada T
Thromb Res; 2008; 123(2):390-5. PubMed ID: 18579183
[TBL] [Abstract][Full Text] [Related]
7. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
8. Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.
Erem C; Kocak M; Hacihasanoglu A; Yilmaz M; Saglam F; Ersoz HO
Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):619-24. PubMed ID: 18484067
[TBL] [Abstract][Full Text] [Related]
9. Relationship of waist and hip circumference with coagulation and fibrinolysis in postmenopausal women.
Peverill RE; Teede HJ; Malan E; Kotsopoulos D; Smolich JJ; McGrath BP
Clin Sci (Lond); 2007 Nov; 113(9):383-91. PubMed ID: 17608627
[TBL] [Abstract][Full Text] [Related]
10. Sialic acid is an inflammation marker associated with a history of deep vein thrombosis.
Reganon E; Vila V; Martínez-Sales V; Vayá A; Mira Y; Ferrando F; Aznar J
Thromb Res; 2007; 119(1):73-8. PubMed ID: 16500696
[TBL] [Abstract][Full Text] [Related]
11. Coagulation and fibrinolytic markers in a two-month follow-up of coronary bypass surgery.
Parolari A; Colli S; Mussoni L; Eligini S; Naliato M; Wang X; Gandini S; Tremoli E; Biglioli P; Alamanni F
J Thorac Cardiovasc Surg; 2003 Feb; 125(2):336-43. PubMed ID: 12579103
[TBL] [Abstract][Full Text] [Related]
12. Influence of aging on the activity of the hemostatic system: prothrombin fragment 1+2, thrombin-antithrombin III complexes and D-dimers in 80 healthy subjects with age ranging from 20 to 94 years.
Cadroy Y; Pierrejean D; Fontan B; Sié P; Boneu B
Nouv Rev Fr Hematol (1978); 1992; 34(1):43-6. PubMed ID: 1523099
[TBL] [Abstract][Full Text] [Related]
13. Fibrinogen, D-dimer and thrombin-antithrombin complexes in a random population sample: relationships with other cardiovascular risk factors.
Giansante C; Fiotti N; Cattin L; Da Col PG; Calabrese S
Thromb Haemost; 1994 May; 71(5):581-6. PubMed ID: 8091384
[TBL] [Abstract][Full Text] [Related]
14. Influence of long term oral anticoagulants upon prothrombin fragment 1 + 2, thrombin-antithrombin III complex and D-Dimer levels in patients affected by proximal deep vein thrombosis.
Elias A; Bonfils S; Daoud-Elias M; Gauthier B; Sié P; Boccalon H; Boneu B
Thromb Haemost; 1993 Apr; 69(4):302-5. PubMed ID: 8497840
[TBL] [Abstract][Full Text] [Related]
15. Thrombin generation markers and coronary heart disease risk factors in a Polish population sample.
Musiał J; Pajak A; Undas A; Kawalec E; Topór-Madry R; Pazucha T; Grzywacz M; Szczeklik A
Thromb Haemost; 1997 Apr; 77(4):697-700. PubMed ID: 9134645
[TBL] [Abstract][Full Text] [Related]
16. D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
Ay C; Vormittag R; Dunkler D; Simanek R; Chiriac AL; Drach J; Quehenberger P; Wagner O; Zielinski C; Pabinger I
J Clin Oncol; 2009 Sep; 27(25):4124-9. PubMed ID: 19636003
[TBL] [Abstract][Full Text] [Related]
17. Activation products of the haemostatic system in coronary, cerebrovascular and peripheral arterial disease.
van der Bom JG; Bots ML; Haverkate F; Meijer P; Hofman A; Kluft C; Grobbee DE
Thromb Haemost; 2001 Feb; 85(2):234-9. PubMed ID: 11246539
[TBL] [Abstract][Full Text] [Related]
18. Effect of apixaban, an oral and direct factor Xa inhibitor, on coagulation activity biomarkers following acute coronary syndrome.
Becker RC; Alexander JH; Newby LK; Yang H; Barrett Y; Mohan P; Wang J; Harrington RA; Wallentin LC
Thromb Haemost; 2010 Nov; 104(5):976-83. PubMed ID: 20806117
[TBL] [Abstract][Full Text] [Related]
19. Low-intensity warfarin reduces thrombin generation and fibrin turnover, but not low-grade inflammation, in men at risk of myocardial infarction.
MacCallum PK; Rudnicka AR; Rumley A; Meade TW; Lowe GD
Br J Haematol; 2004 Nov; 127(4):448-50. PubMed ID: 15521923
[TBL] [Abstract][Full Text] [Related]
20. Prothrombin fragment F1 + 2: correlations with cardiovascular risk factors.
Rugman FP; Jenkins JA; Duguid JK; Maggs PB; Hay CR
Blood Coagul Fibrinolysis; 1994 Jun; 5(3):335-40. PubMed ID: 8075305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]